Transparency in clinical trials is continually changing, and to stay on top of the news, TrialAssure brings a weekly round-up of some of the key stories surrounding disclosures in clinical trials. This week’s stories are as follows:
Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment– BMJ Evidence-Based Medicine
In a recently published article in BMJ Evidence-Based Research, researchers looked at the top 50 biopharmaceutical companies by 2015 sales to see if they made any statements relating to clinical trial data disclosure. The overall mean disclosure rate was 55%.
Read the full article here
Beyond what’s required: thoughtful sharing of clinical trial results – Liz Roberts on LinkedIn
Liz Roberts, Senior Director, Global Policy Lead at UCB, discusses why sharing clinical trial results is important. One way her company discloses results is by making summaries available to patients.
Read Liz Robert’s full piece on LinkedIn
Member news – Forbes Technology Council
In a Forbes Technology Council news roundup, TrialAssure announced the launch of ANONYMIZE DS, an all-new application that uses automation to anonymize clinical trial data. The application is now fully available to the public.
Get the latest news from the Forbes Technology Council here